Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Glen Raffel

Elderly Do Benefit From Induction Chemotherapy: High Dose Mitoxantrone Based (“5+1”) Induction Chemotherapy Regimen in Newly Diagnosed Acute Myeloid Leukemia

American Journal of Hematology

Hematology

2018

English

Role of Recipient CD34 Specific Chimerism (CSC) in the Bone Marrow (BM) to Predict BM Relapse Post Allogeneic (Allo) Stem Cell Transplant (SCT)

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2016

English

Related publications

Micafungin Prophylaxis for Acute Leukemia Patients Undergoing Induction Chemotherapy

English

Efficacy and Toxicity of Idarubicin Versus High-Dose Daunorubicin for Induction Chemotherapy in Adult Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Clinical Lymphoma, Myeloma and Leukemia

English

A Phase I Study of Selinexor in Combination With High-Dose Cytarabine and Mitoxantrone for Remission Induction in Patients With Acute Myeloid Leukemia

Journal of Hematology and Oncology

English

A Randomized Trial of High-Versus Conventional-Dose Cytarabine in Consolidation Chemotherapy for Adult De Novo Acute Myeloid Leukemia in First Remission After Induction Therapy Containing High-Dose Cytarabine

English

Isocitrate Dehydrogenase 1 and 2 Mutations, 2-Hydroxyglutarate Levels, and Response to Standard Chemotherapy for Patients With Newly Diagnosed Acute Myeloid Leukemia

English

Immunologic Consequences of Chemotherapy for Acute Myeloid Leukemia

Journal of Pediatric Hematology/Oncology

English

Secondary Acute Myeloid Leukemia (sAML) Immediately After Intensive Chemotherapy of Acute Lymphoblastic Leukemia (ALL)

Journal of Leukemia

2013

English

High Expression of miR-25 Predicts Favorable Chemotherapy Outcome in Patients With Acute Myeloid Leukemia

Cancer Cell International

English

VATS Pneumonectomy After Induction Chemotherapy

Journal of Clinical and Analytical Medicine

Medicine

2016

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Glen Raffel

Elderly Do Benefit From Induction Chemotherapy: High Dose Mitoxantrone Based (“5+1”) Induction Chemotherapy Regimen in Newly Diagnosed Acute Myeloid Leukemia

Role of Recipient CD34 Specific Chimerism (CSC) in the Bone Marrow (BM) to Predict BM Relapse Post Allogeneic (Allo) Stem Cell Transplant (SCT)

Related publications

Micafungin Prophylaxis for Acute Leukemia Patients Undergoing Induction Chemotherapy

Efficacy and Toxicity of Idarubicin Versus High-Dose Daunorubicin for Induction Chemotherapy in Adult Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

A Phase I Study of Selinexor in Combination With High-Dose Cytarabine and Mitoxantrone for Remission Induction in Patients With Acute Myeloid Leukemia

A Randomized Trial of High-Versus Conventional-Dose Cytarabine in Consolidation Chemotherapy for Adult De Novo Acute Myeloid Leukemia in First Remission After Induction Therapy Containing High-Dose Cytarabine

Isocitrate Dehydrogenase 1 and 2 Mutations, 2-Hydroxyglutarate Levels, and Response to Standard Chemotherapy for Patients With Newly Diagnosed Acute Myeloid Leukemia

Immunologic Consequences of Chemotherapy for Acute Myeloid Leukemia

Secondary Acute Myeloid Leukemia (sAML) Immediately After Intensive Chemotherapy of Acute Lymphoblastic Leukemia (ALL)

High Expression of miR-25 Predicts Favorable Chemotherapy Outcome in Patients With Acute Myeloid Leukemia

VATS Pneumonectomy After Induction Chemotherapy